Overview
Balsam of Peru is a resin that comes from the tree Myroxylon balsamum pereirae. It is constituted by a mixture of substances from which the major components are benzyl cinnamate and Benzyl benzoate. Balsam of Peru has also presented several allergens such as cinnamic acid, Benzyl alcohol and Vanillic acid. Under the FDA, balsam of Peru is considered as an inactive ingredient to be used for approved drug products as well as an approved food additive under the categorization of generally recognized as safe (GRAS). By Health Canada, the balsam of Peru is approved by the use of over-the-counter combination products and it is currently approved in veterinary products. By the EMA, the balsam of Peru is approved and categorized under the herbal medicine products.
Indication
Balsam of Peru is found in diverse cosmetics and perfumes as well as a flavoring agent in cough syrups, lozenges, chewing gum, and candies. As a medical agent, balsam of Peru is used in the local treatment of burns and wounds as an antiseptic. It is also used as an expectorant, heart stimulant to increase blood pressure and as a parasiticide.
Associated Conditions
- Acne
- Decubitus Ulcer
- Dermatitis
- Diaper Rash
- Haemorrhoids
- Incision of the Sclerosed Anorectal Vein
- Incision of the Thrombosed Anorectal Vein
- Open Wound
- Proctitis
- Rash
- Skin Infections
- Venous Stasis Ulcers (VSU)
- Cryptitis
- Pustules
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| Anusol Ointment | 14662 | Medicine | A | 9/20/1991 | |
| Anusol Suppositories strip pack | 14663 | Medicine | A | 9/20/1991 | |
| WELEDA RASH RELIEF CREAM | 354463 | Medicine | A | 2/8/2021 | |
| McGLOINS CHILBLAIN OINTMENT Tube | 11476 | McGloins Pty Ltd | Medicine | A | 8/13/1991 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.